Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9173696 | Journal of Vascular Surgery | 2005 | 7 Pages |
Abstract
We recorded a significant benefit in the microcirculation, a good limb survival rate, and the absence of new trophic lesions. During the follow-up period, no severe complications related to the implanted devices occurred. Because of the diffuse, distal, segmental nature of the disease, SCS should be considered as an alternative treatment modality in patients with Buerger's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Konstantinos P. MD, Stefan MD, PhD, Kiriakos MD, PhD, Svante MD, PhD,